Abstract
Pharmacokinetics do not adequately reflect recovery from cognitive neuromotor impairment induced by most benzodiazepines. This paper examines across time the nature of the relationship of effect to serum concentration of three benzodiazepines. Using the same protocol lorazepam, alprazolam, diazepam and placebo were administered to eight healthy males at doses of 0.057, 0.029, 0.286 and 0.000 mg/kg, body weight, respectively for the first study and at 0.028, 0.014, 0.143 and 0.000 mg/kg, respectively, for the second study. After each dose administration multiple measurements were made over a period of 5.5–11.5 h using two different psychomotor performance tests. Serum drug concentrations were also measured. The profiles for diazepam and alprazolam effects demonstrate a stepwise decrement in the slopes of the concentration versus response curves across time, illustrating the rapid development of acute tolerance. In contrast, lorazepam induced a remarkably constant relationship between concentration and effect across testing intervals.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abernethy DR, Greenblatt DJ, Divoll M, Shader RI (1983) Pharmacokinetics of alprazolam. J Clin Psychiatry 44 (8 pt 2):45–47
Allen OB (1983) A guide to the analysis of growth curve data with special reference to SAS. Comput Biomed Res 16:101–115
Arendt RM, Greenblatt DJ, DeJong RH, Bonin JD, Abernethy DR, Ehrenberg BL, Gwynne Giles H, Sellers EM, Shader RI (1983) In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution. J Pharmacol Exp Ther 227:98–107
Braestrup C, Nielsen M (1983) Benzodiazepine receptors. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology: Biochemical studies of CNS receptors, vol 17. Plenum, New York, pp 285–384
Braestrup C, Albrechtsen R, Squires RF (1977) High densities of benzodiazepine receptors in human cortical areas. Nature 269:702–704
Dubnick B, Lippa AS, Klepner CA, Coupet J, Greenblatt EN, Beer B (1983) The separation of 3H-benzodiazepine binding sites in brain and of benzodiazepine pharmacological properties. Pharmacol Biochem Behav 13:311–318
Ellinwood EH Jr, Linnoila M, Easler ME, Molter DW (1981) Onset of peak impairment after diazepam and after alcohol. Clin Pharmacol Ther 30:534–538
Ellinwood EH Jr, Linnoila M, Easler ME, Molter DW (1983) Profile of acute tolerance to three sedative anxiolytics. Psychopharmacology 80:376–379
Ellinwood EH Jr, Heatherly DG, Nikaido AM, Bjornsson TD, Kilts C (1985) Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam. Psychopharmacology 86:392–399
George KA, Dundee JW (1977) Relative amnesic actions of diazepam, flunitrazepam and lorazepam in man. Br J Clin Pharmacol 4:45–50
Greenblatt DJ (1978) Simultaneous gas-chromatographic analysis for diazepam and its major metabolite, desmethyldiazepam, with use of double internal standardization. Clin Chem 24:1838–1841
Greenblatt DJ, Divoll M (1983) Diazepam versus lorazepam: Relationship of drug distribution to duration of clinical action. In: Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ (eds) Advances in neurology, vol 34. Status epilepticus. Raven, New York, pp 487–491
Greenblatt DJ, Franke K, Shader RI (1978) Analysis of lorazepam and its glucuronide metabolite by electron-capture gas-liquid chromatography. J Chromatogr 146:311–320
Greenblatt DJ, Shader RI, Franke K, MacLaughlin DS, Harmatz JS, Allen MD, Werner A, Woo E (1979) Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. J Pharm Sci 68:57–63
Greenblatt DJ, Ochs HR, Lloyd BL (1980a) Entry of diazepam and its major metabolite into cerebrospinal fluid. Psychopharmacology 70:89–93
Greenblatt DJ, Allen MD, Harmatz JS, Shader RI (1980b) Diazepam disposition determinants. Clin Pharmacol Ther 27:301–312
Greenblatt DJ, Divoll M, Moschitto LJ, Shader RI (1981) Electron-capture gas chromatographic analysis of the triazolobenzodiazepines alprazolam and triazolam. J Chromatogr 225:202–207
Greenblatt DJ, Divoll M, Abernethy DR, Ochs HR, Shader RI (1983) Clinical pharmacokinetics of the newer benzodiazepines. Clin Pharmacokinet 8:233–252
Jack ML, Colburn WA, Spirt NM, Bautz G, Zanko M, Horst WD, O'Brien RA (1983) A pharmacokinetic/pharmacodynamic/receptor binding model to predict the onset and duration of pharmacological activity of the benzodiazepines. Prog Neuropsychopharmacol Biol Psychiatry 7:625–635
Johnson RF, Schenker RK, Roberts RK, Desmond PV, Wilkinson GR (1979) Plasma binding of benzodiazepines in humans. J Pharm Sci 68:1320–1322
Kaplan SA, Jack ML (1983) Metabolism of the benzodiazepines: Pharmacokinetic and pharmacodynamic considerations. In: Costa E (ed) Benzodiazepines: From molecular biology to clinical practice. Raven, New York, pp 173–199
Kothary SP, Pandit SK (1980) Orally administered diazepam and lorazepam: Sedative and amnesic effects. Anesthesiology [Suppl] 53:S18
Kyriakopoulos AA, Greenblatt DJ, Shader RI (1978) Clinical pharmacokinetics of lorazepam. A review. J Clin Psychiatry 39(10 Pt 2):16–23
MacLeod SM, Giles HG, Patzalek G, Thiessen JJ, Sellers EM (1977) Diazepam actions and plasma concentrations following ethanol ingestion. Eur J Clin Pharmacol 11:345–349
Palva ES, Linnoila M (1978) Effect of active metabolites of chlordiazepoxide and diazepam, alone or in combination with alcohol, on psychomotor skills related to driving. Eur J Clin Pharmacol 13:345–350
Reeves PM, Schweizer MP (1983) Aging, diazepam exposure and benzodiazepine receptors in rat cortex. Brain Res 270:376–379
Author information
Authors and Affiliations
Additional information
Research supported by N.I.D.A. Grant DAO1883
Rights and permissions
About this article
Cite this article
Ellinwood, E.H., Nikaido, A.M., Heatherly, D.G. et al. Benzodiazepine pharmacodynamics: evidence for biophase rate limiting mechanisms. Psychopharmacology 91, 168–174 (1987). https://doi.org/10.1007/BF00217057
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00217057